Role of serotonin in cocaine effects in mice with reduced dopamine transporter function

The mesolimbic dopaminergic system, especially the nucleus accumbens, has received attention for its involvement in the reinforcing and addictive properties of cocaine and other drugs of abuse. It is generally accepted that the ability of cocaine to inhibit the dopamine transporter (DAT) is directly related to its reinforcing actions. However, mice with a genetic deletion of the DAT (DAT-KO mice) still experience the rewarding effects of cocaine. These behavioral findings suggest that there is an alternate site for cocaine reinforcement. We demonstrate here that modulation of the serotonergic system in the ventral tegmental area, where the mesolimbic dopamine system originates, is a target of cocaine action. The ultimate effect of this serotonin mechanism in animal models with sustained elevations of dopamine may be a feed-forward enhancement of dopamine levels in the nucleus accumbens.

[1]  R. Christopher Pierce,et al.  A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants , 1997, Brain Research Reviews.

[2]  M. Filip,et al.  Differential Regulation of the Mesoaccumbens Circuit by Serotonin 5-Hydroxytryptamine (5-HT)2A and 5-HT2CReceptors , 2001, The Journal of Neuroscience.

[3]  P. Kalivas,et al.  Repeated cocaine administration into the rat ventral tegmental area produces behavioral sensitization to a systemic cocaine challenge , 2001, Behavioural Brain Research.

[4]  M. Reith,et al.  Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers , 1997, Psychopharmacology.

[5]  P. Garris,et al.  Comparison of Dopamine Uptake in the Basolateral Amygdaloid Nucleus, Caudate‐Putamen, and Nucleus Accumbens of the Rat , 1995, Journal of neurochemistry.

[6]  G. Chiara.  The role of dopamine in drug abuse viewed from the perspective of its role in motivation , 1995 .

[7]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[8]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[9]  R. Wightman,et al.  Profound neuronal plasticity in response to inactivation of the dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Jackson,et al.  Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area. , 1996, European journal of pharmacology.

[11]  T. Ullrich,et al.  3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement , 2002, Psychopharmacology.

[12]  B. Pitt.  Psychopharmacology , 1968, Mental Health.

[13]  L. Porrino,et al.  Differential effects of the pharmacological manipulation of serotonin systems on cocaine and amphetamine self-administration in rats. , 1989, Life sciences.

[14]  E. Nestler.  Molecular mechanisms of drug addiction [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents] , 1992, Neuropharmacology.

[15]  E D Levin,et al.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.

[16]  L. Howell,et al.  Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. , 2002, The Journal of pharmacology and experimental therapeutics.

[17]  M. Millan,et al.  Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5‐HT)1A receptors: WAY 100,635‐reversible actions of the highly selective ligands, flesinoxan and S 15535 , 1998, Synapse.

[18]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[19]  G. Chiara,et al.  Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats , 1989, Neuroscience.

[20]  S. J. Gatley,et al.  Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.

[21]  M. J. Kuhar,et al.  The dopamine hypothesis of the reinforcing properties of cocaine , 1991, Trends in Neurosciences.

[22]  E. Esposito,et al.  Differential effects of acute and chronic fluoxetine administration on the spontaneous activity of dopaminergic neurones in the ventral tegmental area , 1995, British journal of pharmacology.

[23]  E. Esposito,et al.  SB 242 084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system , 1999, Neuropharmacology.

[24]  R. Wise,et al.  Elevated Expression of 5-HT1B Receptors in Nucleus Accumbens Efferents Sensitizes Animals to Cocaine , 2002, The Journal of Neuroscience.

[25]  P. Kalivas,et al.  Neuroadaptations involved in amphetamine and cocaine addiction. , 1998, Drug and alcohol dependence.

[26]  E. Esposito,et al.  Biochemical evidence that the atypical antipsychotic drugs clozapine and risperidone block 5-HT2C receptors in vivo , 2002, Pharmacology Biochemistry and Behavior.

[27]  R. Gainetdinov,et al.  Cocaine self-administration in dopamine-transporter knockout mice , 1998, Nature Neuroscience.

[28]  P. Johansen,et al.  Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: studies in the ventral tegmental area , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  K. Lesch,et al.  Cocaine mechanisms: enhanced cocaine, fluoxetine and nisoxetine place preferences following monoamine transporter deletions , 2002, Neuroscience.

[30]  R. Wightman,et al.  Mechanisms of Amphetamine Action Revealed in Mice Lacking the Dopamine Transporter , 1998, The Journal of Neuroscience.

[31]  K. Nicholson,et al.  Dexfenfluramine lacks amphetamine-like abuse potential , 1996, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[32]  D. Murphy,et al.  Molecular mechanisms of cocaine reward: Combined dopamine and serotonin transporter knockouts eliminate cocaine place preference , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Glowinski,et al.  α1b-Adrenergic Receptors Control Locomotor and Rewarding Effects of Psychostimulants and Opiates , 2002, The Journal of Neuroscience.

[34]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[35]  R. Hen,et al.  Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists , 2000, Pharmacology Biochemistry and Behavior.

[36]  A. Beaudet,et al.  Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons , 1987, Brain Research.

[37]  Donald C. Cooper,et al.  Loss of autoreceptor functions in mice lacking the dopamine transporter , 1999, Nature Neuroscience.

[38]  T. Svensson,et al.  Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. , 1993, European journal of pharmacology.

[39]  J. Glowinski,et al.  d-Amphetamine Fails to Increase Extracellular Dopamine Levels in Mice Lacking α1b-Adrenergic Receptors: Relationship between Functional and Nonfunctional Dopamine Release , 2002, The Journal of Neuroscience.

[40]  J. Daunais,et al.  A comparison of the behavioral effects of the repeated administration of PTT, 2β-propanoyl-3β-(4-tolyl)tropane and cocaine , 2000, Brain Research.

[41]  S. Childers,et al.  Self-administration of cocaine analogs by rats , 1999, Psychopharmacology.

[42]  D. Wilkin,et al.  Neuron , 2001, Brain Research.

[43]  L. Howell,et al.  Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. , 1995, The Journal of pharmacology and experimental therapeutics.

[44]  E. Esposito,et al.  Role of 5-HT(2C) receptors in the control of central dopamine function. , 2001, Trends in pharmacological sciences.

[45]  P. Garris,et al.  Preferential Increases in Nucleus Accumbens Dopamine after Systemic Cocaine Administration Are Caused by Unique Characteristics of Dopamine Neurotransmission , 2000, The Journal of Neuroscience.

[46]  M. Reith,et al.  Effects of Locally Applied Cocaine, Lidocaine, and Various Uptake Blockers on Monoamine Transmission in the Ventral Tegmental Area of Freely Moving Rats: A Microdialysis Study on Monoamine Interrelationships , 1994, Journal of neurochemistry.

[47]  G. Gerhardt,et al.  Differences in Dopamine Clearance and Diffusion in Rat Striatum and Nucleus Accumbens Following Systemic Cocaine Administration , 1992, Journal of neurochemistry.

[48]  T. Sotnikova,et al.  Monoamine transporter pharmacology and mutant mice. , 2002, Trends in pharmacological sciences.

[49]  R. Gainetdinov,et al.  Experimental Genetic Approaches to Addiction , 2002, Neuron.

[50]  G. Baker,et al.  Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food , 1994, Pharmacology Biochemistry and Behavior.

[51]  C. Fiorillo,et al.  Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons , 2001, Nature Neuroscience.